دورية أكاديمية

Role of Hepcidin as a biomarker for iron status in patients on regular hemodialysis.

التفاصيل البيبلوغرافية
العنوان: Role of Hepcidin as a biomarker for iron status in patients on regular hemodialysis.
المؤلفون: El Sharkawy, Magdy M.1, Khedr, Lina Essam1, Hanna, Marco Monir1
المصدر: QJM: An International Journal of Medicine. 2021 Supplement, Vol. 114, pi188-i189. 2p.
مصطلحات موضوعية: *HEPCIDIN, *CHRONIC kidney failure, *BIOMARKERS, *HEMODIALYSIS patients, *ERYTHROCYTES
مستخلص: Background: The etiology of anemia in End Stage Renal Disease is multifactorial. Importantly, ESRD patients also have several abnormalities in systemic homeostasis of iron, an essential component in the production of red blood cells. Aim of the Work: to assess hepcidin level in negative virology End Stage Renal Disease patients & its relation to iron level and erythropoiesis. Patients and Methods: This study was conducted on 45 patients who are stage V chronic kidney disease on regular haemodialysis. Ten age and sex matched controls were included in the study. The study included 29 (64.4%) males and 16 (35.6%) females; their mean age was 53.40611.56 years. The prevalence of diabetes among the studied cases was 17.8%, while that of hypertensive was 42.2%. Mean of serum iron level was 64.23619.53. Mean of TIBC was 409.96667.85. Mean of Ferritin level 394.556139.23 and mean of Hepcidin level was 218.516127. Results: Significant negative correlation between Hepcidin level and the Hemoglobin level, and highly significant positive correlation between Hepcidin level and serum Ferritin. Hepcidin up-regulation in the setting of CKD, with subsequent increased serum levels, results in impaired iron absorption from the intestine and decreased iron release from body storage sites. Ultimately, in the setting of such elevated levels, a state of functional iron deficiency may develop and lead to anemia due to iron-restricted erythropoiesis. Conclusion: Based on current evidence, it seems likely that hep- cidin represents a potentially modifiable mediator of anemia of CKD and is thus a potential target for future anemia therapy. [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:14602725
DOI:10.1093/qjmed/hcab100.084